Acute phase reactants as novel predictors of cardiovascular disease.
about
Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3.Comparative Safety and Efficacy Profile of a Novel Oil in Water Vaccine Adjuvant Comprising Vitamins A and E and a Catechin in Protective Anti-Influenza Immunity.Eryptosis as a marker of Parkinson's diseaseA novel protein glycan biomarker and future cardiovascular disease events.Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever.Host-Imposed Copper Poisoning Impacts Fungal Micronutrient Acquisition during Systemic Candida albicans InfectionsViscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)Significant Increase in C-Reactive Protein and Serum Amyloid A in the Early Hours of Paroxysmal Atrial Fibrillation.Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients.Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis.CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia.CREBH Regulates Systemic Glucose and Lipid Metabolism.Circulation levels of acute phase proteins pentraxin 3 and serum amyloid A in atherosclerosis have correlations with periodontal inflamed surface area.Association of metabolic syndrome and level of hs-CRP, Lp(a), and serum ferritin in young Asian patients (≤45 years) with acute myocardial infarctionACE-inhibition induces a cardioprotective transcriptional response in the metabolic syndrome heart
P2860
Q33742998-1D6DFE40-573E-415D-AFEC-DCBB4A641366Q33749602-1C48063C-5B6F-4F41-809A-D0D966D4A573Q34585744-F5A4A127-0F1C-46AD-BCE3-981BD8ED6B78Q35070814-DAA22550-081F-4A4A-A528-646D7939999CQ35099718-3925EFD5-FEA3-40C5-9B57-306BFAAE18C3Q36064900-C2C22251-1D13-4D8C-A737-EC0C4CDA7807Q36546334-441C324F-3015-48D5-9F78-84A5048A51B6Q37629202-E178D784-8159-4EDC-943C-FDC8561BBFDDQ40269737-72E55C7D-F9B6-4C38-B64F-60FA70DC0793Q40975840-DC3C073A-6112-4F98-B513-D3F3334B69FEQ51028250-9FD0742F-4C1A-4FF0-9AE2-0D78B44DC8CEQ55137606-7BA8AC86-6370-48EF-ADDE-AC8659B31473Q55267249-9BFDC9AC-213D-4A6E-8D89-FF276D9C2532Q58573294-E4B71AF8-681E-4731-BDDD-C725D378C44FQ58577455-4231E616-4CC1-48C3-B9B0-FD073B47665A
P2860
Acute phase reactants as novel predictors of cardiovascular disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Acute phase reactants as novel predictors of cardiovascular disease.
@en
Acute phase reactants as novel predictors of cardiovascular disease.
@nl
type
label
Acute phase reactants as novel predictors of cardiovascular disease.
@en
Acute phase reactants as novel predictors of cardiovascular disease.
@nl
prefLabel
Acute phase reactants as novel predictors of cardiovascular disease.
@en
Acute phase reactants as novel predictors of cardiovascular disease.
@nl
P2093
P2860
P356
P1433
P1476
Acute phase reactants as novel predictors of cardiovascular disease.
@en
P2093
P2860
P304
P356
10.5402/2012/953461
P577
2012-05-06T00:00:00Z